FDA Investigator Christopher N Dedeaux
Christopher N Dedeaux has conducted inspections on 93 sites in 1 countries as of 13 Feb 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
93
Last Inspection Date:
13 Feb 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Christopher N Dedeaux:
Alantis N Griffin,
Alexis O Robinson,
Alissa C Rice,
Anetra E Wyatt,
Anthony D Peterson,
Barbara S Manson,
Brandon C Heitmeier,
Brian S Lynch,
Carl A Huffman, III,
Carmen M Chan,
Cary Greene,
Charles N Dupont,
Cheryl G Scott,
Claire M Minden,
Cody D Rickman,
Combs,
Cynthia L Medlin,
Cynthia R Gibson,
Daniel L Aisen,
Daphne A Videau,
David J Leray,
David R Heiar,
Dawn P Hall,
Debra A Taylor,
Denise J Taylor,
Diana M Guidry,
Diane S Douglas,
Donna D Gallien, MPH,
Edward A Brunt,
Elizabeth D Connell,
Eric R Holm,
Francis A Guidry,
Henry E Sanchez,
Herbert M Corbello,
Herman S Clincy,
Jacquelyn Bradford,
Jason D Abel,
Jeffrey G Baravik,
Jerry T Hunt,
Joseph B Carballa,
June P Page,
Kena M Senegal,
Konsuela Y Glass,
Larry A Estavan,
Laura E Garcia,
Leisha R Shipes,
Llopis,
Mahaffey,
Marcia G Evans,
Marcus A Green,
Margaret E Slimbach,
Marissa R Stough,
Marshall H Kinsey,
Marvin D Jones,
Patrick C Dooley,
Richard L Licari,
Robert W Becker,
Samuel L Collins,
Sandricka M Mosley,
Scott A Watson,
Shannon Atlas,
Sheena R Bailey,
Shelton L Stribling,
Shirhonda D Thorn,
Shymetris M Allen,
Sidney M Smith,
Suzanne R Redmon,
Thomas O Morgan,
Thomas R Stanley,
Verlinda A Narcisse,
Wanda B Coats,
Wayne S Fortenberry,
Wendy R Blame,
William A Warnick
Christopher N Dedeaux's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2017 | FDA 483 | Overton Brooks VA Medical Center - Form 483, 2017-02-17 |
November, 2016 | EIR | Eurofins Analytical Laboratories, Inc. - EIR, 2016-11-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more